Skip to main content
Top
Published in: Annals of Hematology 4/2011

01-04-2011 | Original Article

Random skin biopsy and bone marrow biopsy for diagnosis of intravascular large B cell lymphoma

Authors: Kosei Matsue, Noboru Asada, Jun Odawara, Takayoshi Aoki, Shun-ichi Kimura, Kan-ichi Iwama, Hideaki Fujiwara, Masayuki Yamakura, Masami Takeuchi

Published in: Annals of Hematology | Issue 4/2011

Login to get access

Abstract

Intravascular lymphoma (IVL) is a rare type of extranodal lymphoma in which the lymphoma cells proliferate exclusively in the lumina of small vessels. The diagnosis of IVL requires histological confirmation. Although random skin biopsy from healthy-appearing skin in patients with suspected IVL appeared to be useful, the sensitivity of this method for the diagnosis of IVL remains unknown. We performed a random skin biopsy from 12 consecutive cases of IVL diagnosed at our institution over the past 4 years and evaluate its relevance of clinical and laboratory characteristics, presence or absence of skin lesions, and bone marrow involvement. All 12 patients were diagnosed antemortem by either random skin biopsy or bone marrow biopsy and treated with rituximab-containing chemotherapy. Random skin biopsy was performed in all 12 patients, and the results were positive in ten patients (83.3%). Erythematous skin lesions were seen in 3 of 12 patients, but biopsy was positive for lymphoma lesion in two patients. Bone marrow invasion was seen in 11 of the 12 patients (91.6%) by bone marrow smear and/or flow cytometric analysis, but was detected in only half of the patients by trephine biopsy. We concluded that random skin biopsy from normal-appearing skin is highly sensitive in the diagnosis of IVL comparable to bone marrow trephine biopsy. It should be performed irrespective of the presence or absence of skin lesions in patients who were suspicious of IVL.
Literature
1.
go back to reference Nakamura S, Ponzoni M, Campo E et al (2008) Intravascular large B-cell lymphoma. In: Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, Thiele J, Vardiman JW (eds) WHO classification of tumours of haematopoietic and lymphoid tissues. JARA, Lyon, pp 252–253 Nakamura S, Ponzoni M, Campo E et al (2008) Intravascular large B-cell lymphoma. In: Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, Thiele J, Vardiman JW (eds) WHO classification of tumours of haematopoietic and lymphoid tissues. JARA, Lyon, pp 252–253
2.
go back to reference Asada N, Odawara J, Kimura S et al (2007) Use of random skin biopsy for diagnosis of intravascular large B-cell lymphoma. Mayo Clin Proc 82:1525–1527PubMedCrossRef Asada N, Odawara J, Kimura S et al (2007) Use of random skin biopsy for diagnosis of intravascular large B-cell lymphoma. Mayo Clin Proc 82:1525–1527PubMedCrossRef
3.
go back to reference Matsue K, Asada N, Takeuchi M et al (2008) A clinicopathological study of 13 cases of intravascular lymphoma: experience in a single institution over a 9-yr period. Eur J Haematol 80:236–244PubMedCrossRef Matsue K, Asada N, Takeuchi M et al (2008) A clinicopathological study of 13 cases of intravascular lymphoma: experience in a single institution over a 9-yr period. Eur J Haematol 80:236–244PubMedCrossRef
4.
go back to reference Irving J, Jesson J, Virgo P et al (2009) Establish and valodation of a standard protocol for the detecting of minimal residual disease in B lineage childhood acute lekemia by flow cytometry in a multi-center setting. Haematologica 94:870–874PubMedCrossRef Irving J, Jesson J, Virgo P et al (2009) Establish and valodation of a standard protocol for the detecting of minimal residual disease in B lineage childhood acute lekemia by flow cytometry in a multi-center setting. Haematologica 94:870–874PubMedCrossRef
5.
go back to reference Shimada K, Kinoshita T, Naoe T, Nakamura S (2009) Presentation and management of intravascular large B-cell lymphoma. Lancet Oncol 10:895–902PubMedCrossRef Shimada K, Kinoshita T, Naoe T, Nakamura S (2009) Presentation and management of intravascular large B-cell lymphoma. Lancet Oncol 10:895–902PubMedCrossRef
6.
go back to reference Ponzoni M, Ferreri AJ, Campo E et al (2007) Definition, diagnosis, and management of intravascular large B-cell lymphoma: proposals and perspectives from an international consensus meeting. J Clin Oncol 25:3168–3173PubMedCrossRef Ponzoni M, Ferreri AJ, Campo E et al (2007) Definition, diagnosis, and management of intravascular large B-cell lymphoma: proposals and perspectives from an international consensus meeting. J Clin Oncol 25:3168–3173PubMedCrossRef
7.
go back to reference Janka G, Schneider EM (2004) Modern management of children with haemophagocytic lymphohistiocytosis. Br J Haematol 124:4–14PubMedCrossRef Janka G, Schneider EM (2004) Modern management of children with haemophagocytic lymphohistiocytosis. Br J Haematol 124:4–14PubMedCrossRef
8.
go back to reference Ferreri AJ, Dognini GP, Campo E et al (2007) Variations in clinical presentation, frequency of hemophagocytosis and clinical behavior of intravascular lymphoma diagnosed in different geographical regions. Haematologica 92:486–492PubMedCrossRef Ferreri AJ, Dognini GP, Campo E et al (2007) Variations in clinical presentation, frequency of hemophagocytosis and clinical behavior of intravascular lymphoma diagnosed in different geographical regions. Haematologica 92:486–492PubMedCrossRef
9.
go back to reference Murase T, Yamaguchi M, Suzuki R et al (2007) Intravascular large B-cell lymphoma (IVLBCL): a clinicopathologic study of 96 cases with special reference to the immunophenotypic heterogeneity of CD5. Blood 109:478–485PubMedCrossRef Murase T, Yamaguchi M, Suzuki R et al (2007) Intravascular large B-cell lymphoma (IVLBCL): a clinicopathologic study of 96 cases with special reference to the immunophenotypic heterogeneity of CD5. Blood 109:478–485PubMedCrossRef
10.
go back to reference Murase T, Nakamura S, Kawauchi K et al (2000) An Asian variant of intravascular large B-cell lymphoma: clinical, pathological and cytogenetic approaches to diffuse large B-cell lymphoma associated with haemophagocytic syndrome. Br J Haematol 111:826–834PubMedCrossRef Murase T, Nakamura S, Kawauchi K et al (2000) An Asian variant of intravascular large B-cell lymphoma: clinical, pathological and cytogenetic approaches to diffuse large B-cell lymphoma associated with haemophagocytic syndrome. Br J Haematol 111:826–834PubMedCrossRef
11.
go back to reference Ferreri AJ, Campo E, Seymour JF et al (2004) Intravascular lymphoma: clinical presentation, natural history, management and prognostic factors in a series of 38 cases, with special emphasis on the ‘cutaneous variant’. Br J Haematol 127:173–183PubMedCrossRef Ferreri AJ, Campo E, Seymour JF et al (2004) Intravascular lymphoma: clinical presentation, natural history, management and prognostic factors in a series of 38 cases, with special emphasis on the ‘cutaneous variant’. Br J Haematol 127:173–183PubMedCrossRef
Metadata
Title
Random skin biopsy and bone marrow biopsy for diagnosis of intravascular large B cell lymphoma
Authors
Kosei Matsue
Noboru Asada
Jun Odawara
Takayoshi Aoki
Shun-ichi Kimura
Kan-ichi Iwama
Hideaki Fujiwara
Masayuki Yamakura
Masami Takeuchi
Publication date
01-04-2011
Publisher
Springer-Verlag
Published in
Annals of Hematology / Issue 4/2011
Print ISSN: 0939-5555
Electronic ISSN: 1432-0584
DOI
https://doi.org/10.1007/s00277-010-1101-3

Other articles of this Issue 4/2011

Annals of Hematology 4/2011 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.